1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CTD-2561J22.3 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA TREML4 CTRPv2 pan-cancer AAC -0.085 0.01
mRNA FAM120C CTRPv2 pan-cancer AAC -0.087 0.01
mRNA ARHGEF9 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA PDLIM3 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA RP11-371E8.4 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA MAP3K14 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA CTB-54O9.9 CTRPv2 pan-cancer AAC 0.096 0.01
mRNA RP11-467J12.4 CTRPv2 pan-cancer AAC 0.087 0.01
mRNA ETV4 CTRPv2 pan-cancer AAC 0.09 0.01
Download CSV